Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TIPIDIN TABLET 250 mg

Approval Number

SIN10054P

Drug Name

TIPIDIN TABLET 250 mg

Product Name

TIPIDIN TABLET 250 mg

Approval Date

September 23, 1998

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

B01AC05

ATC Item Name

ticlopidine

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

PT. ACTAVIS INDONESIA

Active Ingredients

Ingredient Name

TICLOPIDINE HCl

Strength

250 mg/tablet

Drug MonographTiclopidine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy